A Study to Explore the Routes of Elimination of MDV3100

Clinical trial NCT01911715 · COMPLETED

Trial details

NCT number: NCT01911715
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics of MDV3100

Start date: 2011-04-01
Primary completion: 2011-07-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.